期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^125I粒子植入治疗前列腺癌研究进展 被引量：2

原文传递
导出
摘要 ^125I放射性粒子植入为前列腺癌的治疗提供了新的可供选择的有效方法，经直肠B超定位，计算机计划后经会阴^125I粒子植入治疗前列腺的应用，达到治疗靶区剂量高分布、对周围正常组织损伤小。尤为适用于早期前列腺癌，本文就^125I粒子特性及其在前列腺癌治疗中的应用现状及进展进行综述。
作者 张春霆(综述) 徐勇(审校)
机构地区 天津医科大学第二医院泌尿外科
出处 《国际泌尿系统杂志》 2011年第5期649-653,共5页 International Journal of Urology and Nephrology
关键词 前列腺肿瘤 碘放射性同位素
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Pasteau O, Degrais P. The radium treatment of cancer of the prnstate. Arch Roentgen Ray, 1914,28:396.
  • 2Whitmore WFJR, Hilaris B, Grabstald H. Retropubic implantation of i- odine 125 in the treatment of prostatic cancer. J Urol, 1972 : 108 - 118.
  • 3NAG S, BEYER D, FRIEDLAND J, et al. American Brachytherapy Society (ABS)reeomm -endations fox transperienal permanent brachytherapy of prostate cancer. Lnt J Radiat Oncol Biol Phys, 1999, 44 (4) :789 -799.
  • 4Holm HH, Juul N, Pedersen JF, et al. Transperineal 1252iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol ,1983,130:283 -286.
  • 5Nag S, BryerD, Friedland J, et al. American Brachytherpy Society (ABS) recommendations for transperienal permanent brachytherpy of prostate cancer. Int J Radiat Onc Biol Phys, 1999,44:789 - 799.
  • 6Grimm PD, Blasko JC, Sylvester JE et al. 10 - year biochemical ( prostate - specific antigen) control of prostate cancer with ( 125 ) 1 brachytherapy[ J]. Int J Radiat Oncol Biol Phys,2001,51 ( 1 ) :31 40.
  • 7Morris WJ, Keyes M, Palma D. et al. Evaluation of dosimetric param- eters and disease response after 125 iodine transperineal brachythera- py for low - and intermediate - risk prostate cancer, Int J Radiat On- col Biol Phys. 2009 Apr 1 ;73(5) :1432 - 1438.
  • 8Stock RG, Cahlon O, Cesaretti JA,et al. Stone NNCombined modality treatment in the management of high - risk prostate cancer. Int J Radi- at Oncol Biol Phys,2004,59 ( 5 ) : 1352 - 1359.
  • 9陈明,孙则禹,张古田,陈恕求,李俊龙,彭涛,戴玉田.经会阴^(125)I粒子组织间植入治疗局限性前列腺癌临床研究(附10例报告)[J].现代泌尿外科杂志,2007,12(2):101-103. 被引量：7
  • 10Gomez - Iturriaga Pia A, Crook J, Borg J, et al. Median 5 year fol- low - up of 125iodine brachytherapy as monotherapy in men aged < or = 55 years with favorable prostate cancer. Urology ,2010,75 ( 6 ) : 1412 -1416.

二级参考文献11

  • 1吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 2Nath R,Anderson LL,Luxton G,et al.Dosimetry of interstitial brachytherapy sources:Recommendations of the AAPM Radiation Therapy Committee Task Group No.43[J].Med Phys,1995,22:209-233.
  • 3Ling CC.Permanent implants using Au-198,Pd-103 and I-125:Radiobiological considerations based on the linear quadratic model[J].Int J Radiat Oncol Biol Phys,1992,23:81-87.
  • 4Nag S,Ribovich M,Cai JZ,et al.Palladium-103 vs.Iodine-125 brachytherapy in the dunning-PAP rat prostate tumor[J].Endocuriether/Hypertherm Oncol,1996,12:119-124.
  • 5Nag S,Beyer D,Friedland J,et al.American Brachytherapy Society(ABS) recommendations for transperineal permanent brachytherapy of prostate cancer[J].Int Radiat Oncol Biol Phys,1995,153:1020-1025.
  • 6Scardino P.Update:NCCN prostate cancer clinical practice guidelines[J].Journal of National Comprehensive Cancer Network,2005,3:29-33.
  • 7Kwok Y,Dibiase SJ,Amin PP,et al.Risk group stratification in patients undergoing permanent 125I prostate brachytherapy as monotherapy[J].Int J Radiation Oncology Bio Phys,2002,53:588-594.
  • 8Ragde H,Blasko JC,Grimm PD,et al.Brachytherapy for clinically localized prostate cancer:result at 7-and 8-year follow-up[J].Sumin Surg Oncol,1997,13:438-443.
  • 9Ragde H,Elgamal AA,Snow PB,et al.Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized,low to high Gleason grade prostate carcinoma[J].Cancer,1998,83:989-1001.
  • 10Vicini FA,Horwitz EM,Kini VR,et al.Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical contronl:a comprehensive review of the literature[J].Int J Radiat Oncol Biol Phys,1998,40:1101-1110.

共引文献6

同被引文献22

  • 1王俊杰,黄毅,冉维强,朱丽红,白静,田素青,李金娜.^(125)I粒子近距离治疗前列腺癌临床应用[J].中华放射医学与防护杂志,2004,24(6):509-512. 被引量：38
  • 2卓水清,陈林,张福君,赵明,张亮,刘健,李奎,吴沛宏,郑庆生,王琰.^(125)I放射性粒子植入术后患者周围辐射剂量的监测[J].癌症,2007,26(6):666-668. 被引量：67
  • 3陈克敏,王忠敏.放射性粒子植入技术临床应用[M].北京: 科学出版社,2011: 7 - 9.
  • 4Morris WJ,Keyes M,Palma D,et al.Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low-and intermediate-risk prostate cancer[J].Int J Radiat Oncol Biol Phys,2009,73(5):1432-1438.
  • 5G6mez-Iturriaga Pifia A,Crook J,Borg J,et al.Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer[J]. Urology, 2010,75(6): 1412-4216.
  • 6Pereira da Ponte Amadei L,Fernandes Silva JL, Abdallah Hanna S,et al. Biochemical control of prostate cancer with iodine-125 brachytherapy alone:experience from a shgle institution[Jl.Clin Transl Oncol, 2012,14(5) : 369-375.
  • 7Beydoun N, Bucci JA, Chin YS,et al. Iodine- 125 thin seeds decrease prostate swelling during transperineal interstitial permanent prostate brachytherapy[J].J Med Imaging Radiat Oncol,2014,58(1) : 109-116.
  • 8Pavlicek Wl,Walton HA,Karstaedt PJ,et al. Radiation safety with use of 1-125 seeds for localization of nonpalpable breast lesions[J]. Acad Radiol, 2006, 13(7) .. 909-915.
  • 9International Commission on Radiological Protection.Radiation safeW aspects of brachytherapy for prostate cancer using permanently implanted sources[R].A report of ICRP Publication 98.Aml I CR P, 2005,35(3) .. iii-vi, 3-50.
  • 10国家卫生和计划生育委员会.GBZl78-2014低能Y射线粒籽源植入治疗放射防护要求与质量控制检测规范[S].国家卫生和计划生育委员会,2014.

引证文献2

二级引证文献25

国际泌尿系统杂志
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部